Monitoring serum beta-2 microglobulin is useful for detecting patients with increased risk of acute rejection during reduction in immunosuppression

Author: Saraiva Camara N.O.   Nishida S.   Silva M.S.   Pestana J.O.M.   Pereira A.B.   Sesso R.   Pacheco-Silva A.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.30, Iss.8, 1998-12, pp. : 4158-4159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content